Erratum: Design of the reduction of events with darbepoetin alfa in heart failure (RED-HF): A phase III, anaemia correction, morbidity-mortality trial (European Journal of Heart Failure (2009) 11 (795-801))
Publication
, Journal Article
McMurray, JJV; Anand, IS; Diaz, R; Maggioni, AP; O'Connor, C; Pfeffer, MA; Polu, KR; Solomon, SD; Sun, Y; Swedberg, K; Tendera, M; Young, JB ...
Published in: European Journal of Heart Failure
July 1, 2010
Duke Scholars
Published In
European Journal of Heart Failure
DOI
EISSN
1879-0844
ISSN
1388-9842
Publication Date
July 1, 2010
Volume
12
Issue
7
Start / End Page
765
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
McMurray, J. J. V., Anand, I. S., Diaz, R., Maggioni, A. P., O’Connor, C., Pfeffer, M. A., … Young, J. B. (2010). Erratum: Design of the reduction of events with darbepoetin alfa in heart failure (RED-HF): A phase III, anaemia correction, morbidity-mortality trial (European Journal of Heart Failure (2009) 11 (795-801)). European Journal of Heart Failure, 12(7), 765. https://doi.org/10.1093/eurjhf/hfq067
McMurray, J. J. V., I. S. Anand, R. Diaz, A. P. Maggioni, C. O’Connor, M. A. Pfeffer, K. R. Polu, et al. “Erratum: Design of the reduction of events with darbepoetin alfa in heart failure (RED-HF): A phase III, anaemia correction, morbidity-mortality trial (European Journal of Heart Failure (2009) 11 (795-801)).” European Journal of Heart Failure 12, no. 7 (July 1, 2010): 765. https://doi.org/10.1093/eurjhf/hfq067.
McMurray JJV, Anand IS, Diaz R, Maggioni AP, O’Connor C, Pfeffer MA, et al. Erratum: Design of the reduction of events with darbepoetin alfa in heart failure (RED-HF): A phase III, anaemia correction, morbidity-mortality trial (European Journal of Heart Failure (2009) 11 (795-801)). European Journal of Heart Failure. 2010 Jul 1;12(7):765.
McMurray, J. J. V., et al. “Erratum: Design of the reduction of events with darbepoetin alfa in heart failure (RED-HF): A phase III, anaemia correction, morbidity-mortality trial (European Journal of Heart Failure (2009) 11 (795-801)).” European Journal of Heart Failure, vol. 12, no. 7, July 2010, p. 765. Scopus, doi:10.1093/eurjhf/hfq067.
McMurray JJV, Anand IS, Diaz R, Maggioni AP, O’Connor C, Pfeffer MA, Polu KR, Solomon SD, Sun Y, Swedberg K, Tendera M, Van Veldhuisen DJ, Wasserman SM, Young JB. Erratum: Design of the reduction of events with darbepoetin alfa in heart failure (RED-HF): A phase III, anaemia correction, morbidity-mortality trial (European Journal of Heart Failure (2009) 11 (795-801)). European Journal of Heart Failure. 2010 Jul 1;12(7):765.
Published In
European Journal of Heart Failure
DOI
EISSN
1879-0844
ISSN
1388-9842
Publication Date
July 1, 2010
Volume
12
Issue
7
Start / End Page
765
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology